Literature DB >> 28320179

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

Benjamin H Natelson1, Xiangling Mao2, Aaron J Stegner, Gudrun Lange3, Diana Vu3, Michelle Blate3, Guoxin Kang2, Eli Soto4, Tolga Kapusuz4, Dikoma C Shungu2.   

Abstract

The purpose of this study was to investigate whether CFS patients without comorbid psychiatric diagnoses differ from CFS patients with comorbid psychiatric diagnoses and healthy control subjects in neuropsychological performance, the proportion with elevated spinal fluid protein or white cell counts, cerebral blood flow (CBF), brain ventricular lactate and cortical glutathione (GSH). The results of the study did not show any differences in any of the outcome measures between CFS patients with and without psychiatric comorbidity, thus indicating that psychiatric status may not be an exacerbating factor in CFS. Importantly, significant differences were found between the pooled samples of CFS compared to controls. These included lower GSH and CBF and higher ventricular lactate and rates of spinal fluid abnormalities in CFS patients compared to healthy controls. Thirteen of 26 patients had abnormal values on two or more of these 4 brain-related variables. These findings, which replicate the results of several of our prior studies, support the presence of a number of neurobiological and spinal fluid abnormalities in CFS. These results will lead to further investigation into objective biomarkers of the disorder to advance the understanding of CFS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28320179      PMCID: PMC5393352          DOI: 10.1016/j.jns.2017.02.046

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  North American Adult Reading Test: age norms, reliability, and validity.

Authors:  Bob Uttl
Journal:  J Clin Exp Neuropsychol       Date:  2002-12       Impact factor: 2.475

2.  Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease.

Authors:  J DeLuca; S K Johnson; S P Ellis; B H Natelson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  A two-year follow-up study of chronic fatigue syndrome comorbid with psychiatric disorders.

Authors:  Yasunori Matsuda; Tokuzo Matsui; Kouhei Kataoka; Ryosuke Fukada; Sanae Fukuda; Hirohiko Kuratsune; Seiki Tajima; Kouzi Yamaguti; Yukiko Hakariya Kato; Nobuo Kiriike
Journal:  Psychiatry Clin Neurosci       Date:  2009-06       Impact factor: 5.188

4.  The assessment of attention: I. Standardization and reliability of a behavior-based measure.

Authors:  M Gordon; B B Mettelman
Journal:  J Clin Psychol       Date:  1988-09

5.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

6.  Illness trajectories in the chronic fatigue syndrome: a longitudinal study of improvers versus non-improvers.

Authors:  Donald S Ciccone; Helena K Chandler; Benjamin H Natelson
Journal:  J Nerv Ment Dis       Date:  2010-07       Impact factor: 2.254

7.  Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.

Authors:  G Lange; J DeLuca; J A Maldjian; H Lee; L A Tiersky; B H Natelson
Journal:  J Neurol Sci       Date:  1999-12-01       Impact factor: 3.181

8.  Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

Authors:  James W Murrough; Xiangling Mao; Katherine A Collins; Chris Kelly; Gizely Andrade; Paul Nestadt; Susan M Levine; Sanjay J Mathew; Dikoma C Shungu
Journal:  NMR Biomed       Date:  2010-07       Impact factor: 4.044

9.  Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Benjamin H Natelson; Diana Vu; Xiangling Mao; Nora Weiduschat; Fumiharu Togo; Gudrun Lange; Michelle Blate; Guoxin Kang; Jeremy D Coplan; Dikoma C Shungu
Journal:  J Pain       Date:  2015-08-31       Impact factor: 5.820

10.  Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.

Authors:  Sanjay J Mathew; Xiangling Mao; Kathryn A Keegan; Susan M Levine; Eric L P Smith; Linda A Heier; Viktor Otcheretko; Jeremy D Coplan; Dikoma C Shungu
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

View more
  8 in total

1.  Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

Authors:  Matthew C Morris; Katherine E Cooney; Hooman Sedghamiz; Maria Abreu; Fanny Collado; Elizabeth G Balbin; Travis J A Craddock; Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-28       Impact factor: 3.393

2.  The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Jin-Mann S Lin; Gudrun Lange; Sarah Khan; Aaron Stegner; Elizabeth R Unger
Journal:  Ann Med       Date:  2019-11-07       Impact factor: 4.709

3.  Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

Authors:  Christina Mueller; Joanne C Lin; Sulaiman Sheriff; Andrew A Maudsley; Jarred W Younger
Journal:  Brain Imaging Behav       Date:  2020-04       Impact factor: 3.978

4.  The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

Authors:  Herbert Renz-Polster; Marie-Eve Tremblay; Dorothee Bienzle; Joachim E Fischer
Journal:  Front Cell Neurosci       Date:  2022-05-09       Impact factor: 6.147

5.  The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Authors:  Iñigo Murga; Larraitz Aranburu; Pascual A Gargiulo; Juan-Carlos Gómez-Esteban; José-Vicente Lafuente
Journal:  J Transl Med       Date:  2021-12-04       Impact factor: 8.440

Review 6.  Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.

Authors:  Anthony L Komaroff; W Ian Lipkin
Journal:  Trends Mol Med       Date:  2021-06-07       Impact factor: 11.951

Review 7.  The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

Authors:  Adam J O'Neal; Maureen R Hanson
Journal:  Front Med (Lausanne)       Date:  2021-06-18

Review 8.  Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.

Authors:  Zack Y Shan; Leighton R Barnden; Richard A Kwiatek; Sandeep Bhuta; Daniel F Hermens; Jim Lagopoulos
Journal:  J Transl Med       Date:  2020-09-01       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.